packageTanezumab

tanezumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tanezumab is an investigational monoclonal antibody analgesic studied for osteoarthritis and chronic pain. It has not been approved; the European Medicines Agency refused a marketing application, so it remains investigational.

Summary written by glm-5.3-flash from Wikidata Q3980782 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:tanezumab
ATC codes:N02BG12
DrugBank:DB12335
Wikidata:Q3980782

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown